VKTX 250516 41.00P(VKTX250516P41000) Stock Price Today

US OptionsDetailed Quotes

VKTX250516P41000

Watchlist

13.32
+0.65+5.13%

15min DelayClose May 14 16:00 ET

13.32High13.32Low

Intraday

5D
Daily

News

Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
Moomoo NewsMay 13 02:31 ET · Ratings
Piper Sandler Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
TipRanksMay 12 07:53 ET · Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
BenzingaMay 9 13:35 ET
Why Viking Therapeutics Stock Was Victorious This Week
Yahoo FinanceMay 2 17:48 ET
Viking Therapeutics Call Volume Above Normal and Directionally Bullish
TipRanksMay 2 15:10 ET
Where Will Viking Therapeutics Be in 3 Years?
Yahoo FinanceMay 2 04:20 ET

Comments

Rade

May 13 04:37

I remember when this stock was 6$. I bought and sold at 20. should have held longer haha

$Viking Therapeutics (VKTX.US)$

FranC327

May 2 21:45

$Viking Therapeutics (VKTX.US)$

Teddy123

Apr 24 11:17

Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

$Viking Therapeutics (VKTX.US)$
Viking Therapeutics Advances Obesity Drug to Phase 3 with $852M War Chest, Reports Q1 Results

Movers and Shakers

Apr 17 20:16

Columns Today's Pre-Market Movers and Top Ratings | TSM, LLY, UNH and More

Morning Movers
Gapping Up
$Hertz Global (HTZ.US)$ soared 17.2%, building on the previous session's momentum. On Wednesday, the stock had already jumped over 56% after Bill Ackman's Pershing Square revealed a significant investment in the company.
$Eli Lilly and Co (LLY.US)$ surged 10.8% in Thursday's premarket trading following the company's announcement that its oral GLP-1 receptor agonist, orforglipron, achieved the primary endpoi...

Semiconductors earnings is approaching, who will continue the "money-making legend"?

ApexTradeZ

Apr 15 07:47

Buyout Opportunity

$Viking Therapeutics (VKTX.US)$
Could the failure of Pfizer's obesity pill force the drugmaker to spend billions on an acquisition to break into the blockbuster weight-loss market wide open???? VKTX becomes more appealing now but who says HIMS doesnt swoop in before Pfizer does??? $Hims & Hers Health (HIMS.US)$
following closely in the next 1 to 3 months VKTX will advance as more data is set to release from trials and their stock returns to 40-50 with a buyout in the 120 - 150 ra...